- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04146870
Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
April 16, 2024 updated by: Sheng-Li Xue, MD, The First Affiliated Hospital of Soochow University
A Survey of Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
The main objectives of this study were :(1) to comprehensively and systematically evaluate the nutritional status of patients after hematopoietic stem cell transplantation.
(2) to explore the effect of nutritional factors on the prognosis of patients treated by hematopoietic stem cell transplantation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study is devised to investigate nutritional status in patients who have undergone hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University.
Evaluation time points include the day before receiving conditioning regimen, post-transplantation 180 days, the nutritional status of patients were systematically evaluated from the aspects of food intake, physical activity level, body composition, blood biochemistry, etc.
Also, the effect of nutritional factors on prognosis of hematopoietic stem cell transplantaion patients will be evaluated.
Study Type
Observational
Enrollment (Estimated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sheng-Li Xue, M.D.
- Phone Number: +86 512 67781139
- Email: slxue@suda.edu.cn
Study Locations
-
-
Jiangsu
-
Suzhou, Jiangsu, China, 215000
- Recruiting
- The First Affiliated Hospital of Suzhou University
-
Contact:
- Sheng-Li Xue, M.D.
- Phone Number: +86 512 67781139
- Email: slxue@suda.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 80 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patients who have received hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University
Description
Inclusion Criteria:
- Patients who undergo hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University.
- Having a life expectancy of more than 3 months
Exclusion Criteria:
- Not willing to participate in the investigation
- Age less than 15 years old or more than 80 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline fat free mass at 6 months
Time Frame: 6 months
|
Body composition analyzer INBO DY S10 (bioelectrical impedance method) is used to analyze the content of fat free mass( kilograms)
|
6 months
|
Change from Baseline fat mass at 6 months
Time Frame: 6 months
|
Body composition analyzer INBODY S10 (bioelectrical impedance method) is used to analyze the content of fat mass( kilograms)
|
6 months
|
Change from Baseline food intake at 6 months
Time Frame: 6 months
|
24-hour dietary record and semi-quantitative food frequency questionnaire are used to evaluate the eating condition of patients
|
6 months
|
Change from Baseline albumin level in blood at 6 months
Time Frame: 6 months
|
The content of albumin in blood is determined.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall survial
Time Frame: 3 years
|
It is measured from the date of entry into this trial to the date of death from any cause; patients not known to have died at last follow-up are censored on the date they were last known to be alive
|
3 years
|
Event free survival
Time Frame: 3 years
|
It is measured from the date of entry into this trial to the date of relapse from CR, or CRi, or death from any cause; patients not known to have any of these events are censored on the date they were last examined.
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2018
Primary Completion (Estimated)
December 30, 2024
Study Completion (Estimated)
December 30, 2024
Study Registration Dates
First Submitted
October 14, 2019
First Submitted That Met QC Criteria
October 30, 2019
First Posted (Actual)
October 31, 2019
Study Record Updates
Last Update Posted (Actual)
April 17, 2024
Last Update Submitted That Met QC Criteria
April 16, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- SZnutri01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hematopoietic Stem Cell Transplantation
-
Washington University School of MedicineNational Marrow Donor Program; Predictive BioDiagnostics, LLCCompletedHematopoietic Stem Cell Transplantation | Stem Cell Transplantation, Hematopoietic | Transplantation, Hematopoietic Stem CellUnited States
-
University Hospital, GenevaRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Hematopoietic Stem Cell Transplantation | Autologous Hematopoietic Stem Cell TransplantationSwitzerland
-
Universitaire Ziekenhuizen KU LeuvenUnknownHematopoietic Stem Cell Transplantation | Hematopoietic Stem Cell Transplantation, Allogeneic
-
Hongnan MoUnknownHematopoietic Stem Cell Transplantation | Thrombocytopoietin | Hematopoietic Stem Cell MobilizationChina
-
National Cancer Institute (NCI)RecruitingHematopoietic Stem Cell TransplantationUnited States
-
Seoul National University HospitalNational Institute of Food and Drug Safety Evaluation (Republic of Korea)RecruitingHematopoietic Stem Cell TransplantationKorea, Republic of
-
University of Michigan Rogel Cancer CenterRecruitingHematopoietic Stem Cell TransplantationUnited States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...CompletedHematopoietic Stem Cell TransplantationBrazil
-
Seoul National University HospitalCompletedHematopoietic Stem Cell TransplantationKorea, Republic of
-
University of OsloRecruitingHematopoietic Stem Cell TransplantationNorway
Clinical Trials on not have
-
Biocity Biopharmaceutics Co., Ltd.RecruitingHematologic MalignancyChina
-
Shirley Lima CamposUniversidade Federal de Pernambuco; Conselho Nacional de Desenvolvimento Científico...Recruiting
-
Yazd Research & Clinical Center for InfertilityCompleted
-
Zhujiang HospitalRecruiting
-
yu li,MDRecruitingMagnetic Resonance Imaging | Non-Alcoholic Fatty Liver Disease | Bariatric SurgeryChina
-
Sun Yat-sen UniversityCompleted
-
Catholic Kwandong UniversityCompletedType 2 Diabetes Mellitus | ColonoscopyKorea, Republic of
-
Meir Medical CenterUnknownAdmission to the NICU and Need for Physiological Monitoring.Israel
-
University College, LondonUnknownDementia, Alzheimer, Electronic Health Records, Hospitalizations, Epidemiology, Comorbidity, United Kingdom, Incidence, Mortality, Cause of Death
-
University College, LondonUnknownAtrial Fibrillation | Epidemiology